Titre:
  • OKT3 serum levels as a guide for prophylactic therapy: a pilot study in kidney transplant recipients
Auteur:Abramowicz, Daniel; Goldman, Michel; Mat, Olivier; Estermans, G.; Crusiaux, Alain; Vanherweghem, Jean-Louis; De Pauw, Luc; Kinnaert, Paul; Vereerstraeten, Pierre
Informations sur la publication:Transplant International, 7, 4, page (258-263)
Statut de publication:Publié, 1994-07
Sujet CREF:Néphrologie - urologie
Transplantation d'organes
Essais, contrôle médicaments
MeSH keywords:Adult
Graft Enhancement, Immunologic -- methods
Graft Rejection -- prevention & control
Humans
Kidney Transplantation -- immunology
Muromonab-CD3 -- adverse effects
Muromonab-CD3 -- blood
Muromonab-CD3 -- therapeutic use
Pilot Projects
Note générale:Clinical Trial
Journal Article
Randomized Controlled Trial
Research Support, Non-U.S. Gov't
FLWNA
Langue:Anglais
Identificateurs:urn:issn:0934-0874
info:doi/10.1111/j.1432-2277.1994.tb01571.x
info:pmid/7916925
jlv-0096